| Financial Year |
March 31 2023 |
| Monetary Funds |
455,072,022.11 |
| Held-for-trading Financial Assets |
1,139,000,000.00 |
| Notes Receivable |
141,997,195.50 |
| Accounts Receivable |
1,413,414,940.33 |
| Advances to Suppliers |
130,083,019.66 |
| Other Receivables |
28,928,562.68 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
170,388,870.88 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
51,868,601.72 |
| Total Current Assets |
3,786,896,715.55 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
3,353,200.70 |
| Fixed Assetes |
202,902,355.76 |
| Under-construction Projects |
182,692,297.19 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
83,590,361.42 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
389,549.59 |
| Deferred Income Tax Assets |
32,234,552.36 |
| Other Non-Current Assets |
190,991,146.15 |
| Sub-Total of Non-Current Assets |
708,304,742.60 |
| Total Assets |
4,495,201,458.15 |
| Short-Term Loans |
160,686,140.23 |
| Trading Financial liabilities |
-- |
| Notes Payable |
441,257,892.71 |
| Accounts Payable |
412,365,904.18 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
6,826,922.10 |
| Taxes Payable |
49,209,287.66 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
4,999,388.62 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,865,482.66 |
| Other Current Liabilities |
49,304,346.75 |
| Sub-Total of Current Liabilities |
1,336,663,781.74 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
21,114,642.39 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
22,134,028.54 |
| Total Liabilities |
1,358,797,810.28 |
| Paid-In Capital(Or Share Stock) |
171,471,695.00 |
| Capital Surplus |
2,002,881,919.48 |
| Surplus Reserve |
104,121,990.56 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
857,725,811.76 |
| Minority Stockholder's Interest |
350,179.47 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,136,053,468.40 |
| Owner's Equity（Stockholder's Equity） |
3,136,403,647.87 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,495,201,458.15 |
